Survodutide shows promising results in Phase 2 study for weight loss in obese people

Pallavi Madhiraju- June 24, 2023 0

Boehringer Ingelheim and Zealand Pharma have announced further data showcasing the superior efficacy of survodutide (BI 456906) compared to placebo in individuals with overweight or ... Read More